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Abstract
Background: The prevalence of allergy-related diseases (ARDs), including rhinitis, 
allergic conjunctivitis and eczema, is on the increase globally. The causes of this in-
crease are not well established.
Objectives: To investigate the risk factors associated with ARDs among schoolchil-
dren in Uganda.
Methods: We conducted a secondary data analysis of a large asthma case–control 
study involving 1700 schoolchildren, 5–17 years, in urban Uganda. ARDs were de-
fined according to the International Study of Asthma and Allergies in Childhood 
(ISAAC) questionnaire. Skin prick testing (SPT) was conducted using standard pro-
cedures and allergen-specific IgE (asIgE) using ImmunoCAP®. We employed inverse 
probability weighted analysis to generate estimated prevalence data and weighted 
odds ratios.
Results: The lifetime estimated weighted prevalence of reported rhinitis, allergic 
conjunctivitis and eczema was 43.3%, 39.5% and 13.5%; weighted prevalence in 
12 months was 10.1%, 9.1% and 2.3%, respectively. There was overlap of ARDs, with 
66.3% of 1193 schoolchildren who reported having ever an ARDs (including asthma) 
reporting two or more. Risk factors associated with reported rhinitis in the last 
12 months were city residence at birth [adjusted odds ratio (95% confidence inter-
val) 2.66 (1.42–4.99) compared to rural]; father's [2.62 (1.79–3.83)] and mother's his-
tory of allergic disease [2.12 (1.48–3.02)]; frequent de-worming in the last 12 months 
[2.01 (1.30–3.11), ≥2 versus none]; current high frequency of ‘trucks passing on the 
street near home’ [2.59 (1.48–4.52), ‘almost all the time’ versus rarely] and positive 
SPT [1.54 (1.09–2.18)] but not asIgE [1.38 (0.60–3.15)]. The same pattern of risk fac-
tors was observed for allergic conjunctivitis and eczema.
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1  | INTRODUC TION
Allergy-related diseases (ARDs) including rhinitis, allergic conjuncti-
vitis and eczema are on the increase in most parts of the world,1,2 but 
the causes of these diseases are generally not established.3 These 
chronic recurrent conditions cause significant physical and psycho-
logical distress, sleep disturbance and reduced quality of life among 
people of all ages, but particularly among children.3,4 The worldwide 
prevalence is estimated as 42% for rhinitis,2 25% for allergic con-
junctivitis4 and 8% for eczema.5 Studies from high-income countries 
have demonstrated that these ARDs often coexist,6,7 but data from 
population studies in sub-Saharan Africa are scarce.
In Africa, and other low- and middle-income countries (LMICs), 
the prevalence of these conditions is higher in urban than rural 
areas.8–11 Although data on risk factors for ARDs from Africa are 
scarce, there is evidence to suggest that there may be important dif-
ferences in risk factors between high-income countries (HICs) and 
LMICs. For example, the International Study of Asthma and Allergies 
in Childhood (ISAAC) study reported a weaker association between 
ARDs and allergic sensitization in LMICs than in HICs.12 These dif-
ferences were also supported by results from our own work on 
risk factors for asthma, another important ARD, among Ugandan 
schoolchildren.13 Children born in rural areas had the lowest asthma 
risk, but this was not associated with exposure to farm animals in 
early life13 as has been found in Europe14,15 and North America.16,17 
Childhood asthma was also associated with a higher parental educa-
tion and social economic status,13 in contrast to HICs where asthma 
is associated with low parental education and social economic sta-
tus.18,19 Understanding the risk factors for ARDs in Africa is key to 
identifying the causes of these conditions and will inform local in-
tervention strategies for prevention and treatment. We therefore 
undertook a secondary data analysis of a large asthma case–control 
study involving schoolchildren in urban Uganda, in order to investi-
gate the risk factors associated with rhinitis, allergic conjunctivitis 
and eczema.
2  | METHODS
This was a secondary analysis of data from an asthma cross-sectional 
case–control study (ie disease status—case or control—is measured 
at one point in time).13 For this paper, we used statistical tools that 
enabled us to analyse the data as a general cross-sectional study. 
The statistical tool is inverse probability weighted analysis (detailed 
explanation in the statistics section below). The data that support 
the findings of this study are available in London School of Hygiene 
& Tropical Medicine Data Compass at http://datac ompass.lshtm.
ac.uk/1761/. Data access is restricted due to the presence of poten-
tial identifiers. To gain access, interested parties are asked to com-
plete a data request, indicating the requested values (codebook for 
details freely available), and sign a data agreement. We report our 
findings according to the STROBE guidelines.20
2.1 | Study population and enrolment procedures
Schoolchildren, 5–17 years, were enrolled from both primary and sec-
ondary schools in an urban area of Wakiso district in central Uganda 
between May 2015 and July 2017; further details of the study are 
described elsewhere.13,21 For each child with asthma (‘cases’), two 
children without a history of asthma symptoms (‘controls’) were ran-
domly selected from the class register, using a random number gen-
erator programme in STATA (StataCorp). The parents or guardians 
of potential participants were contacted to attend a meeting, using 
invitation cards delivered by the children or telephone calls by the 
study team. During the meeting, parents/guardians who were inter-
ested in having their children participate provided written informed 
consent. Children 8 years or older provided written informed assent.
The study conforms to the standards of the Declaration of Helsinki 
and was approved by the Uganda Virus Research Institute Research 
and Ethics Committee (reference number GC/127/14/09/481) and 
by the Uganda National Council for Science and Technology (refer-
ence number HS 1707).
2.2 | Study procedures
Data on rhinitis, allergic conjunctivitis and eczema were collected 
using the widely used and validated ISAAC questionnaire,22 which 
was administered by the study team in either English or Luganda (a 
language widely understood by the study population). Rhinitis was 
defined as ‘a problem with sneezing, or a runny, or a blocked nose 
when you did not have a cold or the flu’; allergic conjunctivitis was 
defined as ‘recurrent itchy-watery eyes’; eczema was defined as ‘an 
itchy rash which was coming and going for at least 6 months, and 
in any of the following places: the folds of the elbows, behind the 
knees, in front of the ankles, under the buttocks or around the neck, 
ears or eyes’. We included an additional question for urticarial rash 
which was defined as ‘itchy rash associated with wheals (ebilogologo 
in Luganda, a well-known terminology). Questions were answered 
Conclusion: We found extensive multi-morbidity of, and overlap in the risk factors 
for, rhinitis, conjunctivitis and eczema—similar to asthma risk factors—among school-
children in urban Uganda. This suggests a similar underlying cause for all ARDs, as-
sociated with exposure to urban lifestyles and environment in Uganda.
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by either the parents or the participant themselves (for adolescents). 
We used the ISAAC environmental questionnaire23 to collect data 
on risk factors for ARDs and added questions relevant to this set-
ting, such as residence at birth and in the first 5 years of life [rural or 
urban (small town or the city Kampala)] and frequency of de-worm-
ing in the last 12 months.
We conducted assessments for allergic sensitization. Skin prick 
testing (SPT) was conducted using standard procedures24 with 
seven crude allergen extracts [Dermatophagoides mix of D. fari-
nae and D. pteronyssnus (dust mite), Blomia tropicalis (dust mite), 
Blattella germanica (cockroach), Arachis hypogaea (peanut), cat, pol-
len mix of weeds, mould mix of Aspergillus species; ALK Abello, 
Hoersholm, Denmark]. Fractional exhaled nitric oxide (FENO) 
was measured using a handheld device (NoBreath®, Bedfont 
Scientific). We used the manufacturer's cut-off for children of ≥35 
parts per billion. For allergen-specific IgE (asIgE), 200 aliquots of 
plasma were randomly selected from all participants for testing 
by ImmunoCAP® (Phadia)25 using three crude allergen extracts 
(D. pteronyssinus, B germanica and Arachis hypogaea). The standard 
cut-off for allergic sensitization of ≥0.35 allergen-specific kilo 
units per litre (kUA/L) was used. Total IgE was also measured using 
ImmunoCAP®.
Other assessments included the tuberculin skin test (TST), stool 
examinations and HIV testing. TST was conducted using standard 
procedures we have described previously.26 Examination for hel-
minths was conducted on three stool samples freshly collected on 
different days, using the Kato Katz method,27 and these included 
Schistosoma mansoni, Trichuris trichuria, hookworm and Ascaris lum-
bricoides. As part of the Uganda Ministry of Health (MoH) directive, 
all children enrolled in the study were tested for HIV, using rapid test 
kits, according to the MoH algorithm.28
2.3 | Statistical considerations
Data were collected on paper questionnaires and double data 
entered into OpenClinica open-source software version 3.1.4 
(OpenClinica LLC and collaborators). Cleaned data were transferred 
to STATA version 15 for analysis. Variables with clinically relevant 
standard cut-off points, such as SPT, asIgE, FENO and TST, were 
analysed as binary variables. Total IgE was analysed as a continu-
ous variable. The variable father's and mother's ‘history of allergic 
disease’ included a history of asthma, rhinitis, conjunctivitis, eczema 
and any other allergies such as urticaria.
We generated an additional variable for any allergy-related 
disease which we defined as existence of any of rhinitis, allergic 
conjunctivitis, eczema and asthma. This was in recognition of the 
evidence from literature that these conditions frequently coexist,6,7 
suggesting the possibility of similar underlying risk factors that this 
study aimed to investigate.
This was a secondary analysis of data from an asthma case–
control study, and therefore, it was not a random population sam-
ple. We therefore used inverse probability weighting which takes 
into account the fact that asthma cases and non-asthma controls 
were sampled with different probabilities of selection into the 
case–control study.29 This tool uses differential weighting, by giv-
ing each individual's data a weight inversely proportional to their 
probability of selection. Inverse probability weighting was imple-
mented as follows. The population prevalence of asthma in urban 
Uganda is approximately 12%,30 and the original asthma case–
control study enrolled all identified asthma cases in the population 
under study [in Wakiso District] and randomly selected twice the 
number of controls.13 One might therefore expect that for every 
100 children in the source population, there would be 12 asthma 
cases and 24 non-asthmatic controls (out of 88 non-asthmat-
ics) selected. We therefore assumed that all cases in the source 
population were sampled and that the sampling fraction in the 
non-asthmatics was 24/88 (0.273). We used inverse probability 
weighting to account for these sampling fractions in all our analy-
ses, that is asthma cases received a weight of 1, whereas non-asth-
matics received a weight of 3.67 (=1/0.273).
Using the weighted analysis, we estimated the weighted prev-
alence of rhinitis, allergic conjunctivitis and eczema. We used chi-
squared tests for comparison of the different risk factors among 
children with or without a given allergy-related condition. We built 
each multiple logistic regression model by adding one confounder 
(identified in literature and in preliminary analyses of the data) at 
a time and noted the change in effect side, we stopped adding 
when there was no change in effect size.31 Variables that were 
strongly related (such as mother's and father's education or area 
of residence at birth and area of residence in the first 5 years) were 
not included in the same model in order to minimize problems of 
collinearity.31
In order to investigate whether the results on risk factors asso-
ciated with rhinitis, allergic conjunctivitis and eczema were being 
driven by asthma comorbidity, we conducted a subgroup analysis 
among schoolchildren with and without asthma separately and 
obtained similar findings. We present results from the weighed 
analysis.
3  | RESULTS
We present results from the weighted analysis that included all 
1700 schoolchildren enrolled in the original asthma case–control 
study32; the detailed participant flow diagram has been published 
previously.13
3.1 | Weighted prevalence of rhinitis, allergic 
conjunctivitis and eczema
The lifetime estimated weighted prevalence of reported rhinitis, 
allergic conjunctivitis and eczema was 43.3%, 39.5% and 13.5%, 
respectively, while the weighted prevalence in the last 12 months 
was 10.1%, 9.1% and 2.3%, respectively (Table 1). There was overlap 
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of these ARDs (Table 1); of the 1193 schoolchildren who reported 
having ever had ARDs, 791 (66.3%) reported either two, three or 
four ARDs. The lifetime weighted prevalence of urticarial rash and 
weighted prevalence in the last 12 months was 31.9% and 1.8%, re-
spectively (Table 1). The overall weighted prevalence of positive skin 
prick test (to any of seven allergens) at enrolment was 34.7%.
For the rest of the analysis, the main outcomes are reported 
rhinitis in the last 12 months, the lifetime history of allergic con-
junctivitis, eczema (because of larger numbers compared to the 
prevalence of these same conditions in the last 12 months) and the 
combined variable of any allergy-related diseases (that includes 
asthma).
3.2 | Risk factors associated with rhinitis
Schoolchildren with reported rhinitis in the last 12 months were more 
likely than their counterparts without rhinitis to report a father's [ad-
justed odds ratio (95% confidence interval), 2.62 (1.79–3.83)]; and 
mother's history of allergic disease [2.12 (1.48–3.02)]; residing in 
the city at birth [2.66 (1.42–4.99)]; using firewood/charcoal stove as 
main fuel for indoor cooking [2.46 (1.53–3.97)]; the highest reported 
frequency of de-worming in the last 12 months [2.01 (1.30–3.11)]; 
and the highest reported frequency of ‘trucks passing on the street 
near their home’ currently [2.59 (1.48–4.52)] (Table 2). They were 
more likely to have a positive skin prick test [1.54 (1.09–2.18)] and 
elevated FENO levels [1.66 (1.14–2.40)], but there were no differ-
ences for asIgE and total IgE (Table 2). Similar results were observed 
for lifetime history of rhinitis, albeit narrower confidence intervals 
were observed, due to bigger numbers (Table S1).
3.3 | Risk factors associated with allergic 
conjunctivitis
Schoolchildren with a lifetime history of allergic conjunctivitis were 
more likely than their counterparts without allergic conjunctivitis 
to report a father's [2.06 (1.56–2.71)] and mother's history of al-
lergic disease [1.57 (1.24–1.98)]; residing in the city at birth [1.69 
(1.09–2.64)]; being exposed to farm animals in early life [1.33 (1.05–
1.67)]; having a father with tertiary education [1.35 (1.03–1.79)]; the 
highest reported frequency of de-worming in last 12 months [1.94 
(1.44–2.63)]; and the highest reported frequency of ‘trucks passing 
on the street near their home’ currently [1.60 (1.03–2.48)] (Table 3). 
They were more likely to have a positive SPT [1.76 (1.40–2.21)] and 
elevated FENO levels [1.57 (1.20–2.05)], but there was no difference 
for asIgE and total IgE (Table 3). Similar results were observed for 
allergic conjunctivitis in the last 12 months, albeit with wider confi-
dence intervals due to much smaller numbers.
3.4 | Risk factors associated with eczema
Children with a lifetime history of eczema were more likely than their 
counterparts without eczema to report a father's [2.19 (1.56–3.09)] 
and mother's history of allergic disease [1.94 (1.42–2.67)]; residing in 
the city at birth [1.55 (0.91–2.63)]; the highest reported frequency 
of de-worming in last 12 months [1.63 (1.10–2.43)]; and the high-
est reported frequency of ‘trucks passing on the street near their 
home’ currently [1.94 (1.14–3.32)], but there were no differences for 
SPT, asIgE and total IgE (Table 4). Numbers for eczema in the last 
12 months were small.
Allergy-related diseases (ARDs)
Ever Last 12 months
n Weighted % n Weighted %
1. Overall
Rhinitis 870 43.3 216 10.1
Allergic conjunctivitis 772 39.5 179 9.1
Eczema 265 13.5 60 2.3
Urticarial rash 572 31.9 36 1.8
2. ARDs overlap
None (of the four ARDs) 498 38.8 959 74.8
Asthma only 60 1.3 388 8.3
Rhinitis only 171 13.3 63 4.9
Conjunctivitis only 144 11.2 59 4.6
Eczema only 27 2.1 16 1.3
2 ARDS 396 21.6 134 4.5
3 ARDs 308 9.9 63 1.4
4 ARDs 87 1.8 7 0.2
Total 1691a 100 1689b 100
Note: Missing numbers: a = 9, b = 11. Overall, 1193 (61.2%) reported at least one ARD ever, and 730 
(25.2%) in the last 12 months.
N, number; %, percentage.
TA B L E  1   Weighted prevalence 
of allergy-related diseases among 
schoolchildren in Uganda (N = 1700)
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TA B L E  2   Risk factors for current rhinitis among Ugandan schoolchildren (N = 1691)
Characteristics
Rhinitis, last 12-months
Adj. OR1  (95% CI) p-valueYes (N = 216) No (N = 1475)
Age, years Mean (SD) 11.71 11.00 1.05 (0.99–1.12) .10
Girls (941) 122 (56.5) 819 (55.5) 0.88 (0.62–1.23) .45
Father's history of allergic disease [m = 149]
Yes (363) 80 (41.4) 283 (21.0) 2.62 (1.79–3.83) <.0001
Mother's history of allergic disease [m = 126]
Yes (592) 102 (51.8) 490 (35.8) 2.12 (1.48–3.02) <.0001
Area of residence at the time of the child's birth [m = 1]
Rural (354) 33 (15.3) 321 (21.8) 1 .01
Town (1187) 154 (71.3) 1033 (70.1) 1.49 (0.95–2.34)
City (149) 29 (13.4) 120 (8.1) 2.66 (1.42–4.99)a
Child's area of residence in first 5 years of life [m = 1]
Rural (339) 28 (13.0) 311 (21.1) 1 .03
Town (1265) 174 (80.5) 1091 (74.0) 1.91 (1.19–3.06)
City (86) 14 (6.5) 72 (4.9) 1.99 (0.86–4.60)b
Exposure to animals in first 5 years of life [m = 58]
Yes (614) 90 (43.1) 524 (36.8) 1.43 (1.00–2.05) .05
Frequency of ‘trucks passing on street near child's home’ at enrolment [m = 1]
Rarely (943) 108 (50.0) 835 (56.6) 1 .003
Frequently (624) 79 (36.6) 545 (37.0) 1.03 (0.71–1.48)
Almost all the time (123) 29 (13.4) 94 (6.4) 2.59 (1.48–4.52)c
Main source of fuel used for indoor cooking [m = 1]
No indoor cooking (394) 33 (15.3) 361 (24.5) 1 .0007
Firewood/charcoal stove (906) 144 (66.6) 762 (51.7) 2.46 (1.53–3.97)
Paraffin stove (145) 14 (6.5) 131 (8.9) 1.47 (0.68–3.18)
Electricity or gas (245) 25 (11.6) 220 (14.9) 1.13 (0.59–2.17)
Use of de-worming medication in last 12 months [m = 2]
None (577) 63 (29.3) 514 (34.9) 1 .002
Once (732) 79 (36.7) 653 (44.3) 1.02 (0.68–1.53)
≥Twice (380) 73 (34.0) 307 (20.8) 2.01 (1.30–3.11)d
Any helminth infection at enrolment [m = 130]
Yes (212) 23 (11.5) 189 (13.9) 0.86 (0.50–1.47) .58
Tuberculin skin test induration at enrolment [N = 960]
Positive (≥10 mm) (143) 19 (15.4) 124 (14.8) 0.74 (0.39–1.40) .36
Skin Prick Test response to any of 7 allergens at enrolment [m = 36]
Positive (≥3 mm) (657) 108 (51.4) 549 (38.0) 1.54 (1.09–2.18) .01
Fractional exhaled nitric oxide levels at enrolment [m = 80]
Elevated (≥35 ppb) (381) 75 (34.9) 306 (21.9) 1.66 (1.14–2.40) .007
Allergen-specific IgE at enrolment (N = 397)2 
Atopic (≥0.35 kUA/L) (251) 38 (70.4) 213 (62.1) 1.38 (0.60–3.15) .45
Total IgE (N = 398) Median (95% CI) kU/L 468.2 (178.0–828.7) 330.5 (271.5–410.7) 1.0001 (0.9998–1.0003) .61
Abbreviations: Adj. OR, adjusted odds ratio; CI, confidence interval; m = missing; N, number; SD, standard deviation; Columns 2 and 3 represent 
number (%).
1Adjusted for child's age, sex, area of residence at birth and father's education. Test for trend p-valve: a = 0.08; b = 0.004; c = 0.006; d = 0.02; 
2ImmunoCAP® cut-off > 0.35 kUA/L. 
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3.5 | Risk factors associated with ARDs combined
Because of the high rate of multi-morbidity of ARDs (Table 1) and the 
high overlap of risk factors associated with these conditions (Tables 2-
4), we created a new variable that combined all the ARDs (including 
asthma) and compared children with any ARD to children who did 
not report any ARDs. We found the risk factors associated with ‘any 
ARD ever’ to include a father's [2.64 (1.89–3.70)] and mother's his-
tory of allergic disease [2.21 (1.70–2.86)]; city residence at birth [2.12 
(1.26–3.57)]; exposure to farm animals in first 5 years of life [1.41 
TA B L E  3   Risk factors for allergic conjunctivitis among schoolchildren in Uganda (N = 1691)
Characteristics
Conjunctivitis ever
Adj. OR1  (95% CI) p-valueYes (N = 772) No (N = 919)
Age, years Mean (SD) 11.45 (3.10) 10.80 (3.12) 1.06 (1.02–1.10) .002
Girls (942) 430 (55.7) 512 (55.7) 1.02 (0.82–1.27) .83
Father's education [m = 20]
None/Primary (437) 172 (22.4) 265 (29.3) 1 .08
Secondary (595) 284 (37.1) 311 (34.4) 1.28 (0.97–1.69)
Tertiary (639) 310 (40.5) 329 (36.3) 1.35 (1.03–1.79)a
Father's history of allergic disease [m = 148]
Yes (363) 222 (31.2) 141 (17.0) 2.06 (1.56–2.71) <.0001
Mother's history of allergic disease [m = 125]
Yes (592) 315 (43.4) 277 (32.9) 1.57 (1.24–1.98) <.0001
Area of residence at the time of the child's birth
Rural (354) 158 (20.5) 196 (21.3) 1 .006
Town (1188) 523 (67.7) 665 (72.4) 0.89 (0.68–1.16)
City (149) 91 (11.8) 58 (6.3) 1.69 (1.09–2.64)b
Exposure to animals in first 5 years of life [m = 58]
Yes (615) 296 (39.7) 319 (35.9) 1.33 (1.05–1.67) .02
Frequency of ‘trucks passing on street near child's home’ at enrolment
Rarely (944) 411 (53.2) 533 (58.0) 1 .05
Frequently (624) 290 (37.6) 334 (36.3) 1.06 (0.84–1.34)
Almost all the time (123) 71 (9.2) 53 (5.7) 1.60 (1.03–2.48)c
Use of de-worming medication in last 12 months [m = 1]
None (578) 228 (29.6) 350 (38.1) 1 <.0001
Once (732) 320 (41.5) 412 (44.8) 1.09 (0.85–1.40)
≥Twice (380) 223 (28.9) 157 (17.1) 1.94 (1.44–2.63)d
Any helminth infection at enrolment [m = 129]
Yes (212) 87 (12.1) 125 (14.8) 0.88 (0.63–1.22) .44
Tuberculin skin test induration at enrolment [N = 960]
Positive (≥10 mm) (143) 58 (13.9) 85 (15.6) 0.68 (0.45–1.05) .08
Skin Prick Test response to any of 7 allergens at enrolment [m = 35]
Positive (≥3 mm) (657) 368 (48.9) 289 (32.0) 1.76 (1.40–2.21) <.0001
Fractional exhaled nitric oxide levels at enrolment [m = 79]
Elevated (≥35 ppb) (381) 227 (30.2) 154 (17.9) 1.57 (1.20–2.05) .001
Allergen-specific IgE at enrolment (N = 397)2 
Atopic (≥0.35 kUA/L) (251) 136 (67.3) 155 (59.0) 1.22 (0.75–1.98) .41
Total IgE at enrolment (N = 398)
Median (95% CI) kU/L 335.2 (250.7–457.6) 335.8 (270.9–420.0) 0.9999 (0.9997–1.0001) .28
Abbreviations: Adj. OR, adjusted odds ratio; CI, confidence interval; m, missing; N, number; SD, standard deviation; Columns 2 and 3 represent 
number (%), unless stated otherwise.
1Adjusted for child's age, sex, area of residence at birth and father's education. Test for trend p-value: a = 0.03; b = 0.22; c = 0.09; d < 0.0001. 
2ImmunoCAP®, cut-off > 0.35 kUA/L. 
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(1.11–1.80)]; the highest reported frequency of de-worming in the last 
12 months [2.12 (1.51–2.99)]; and ‘trucks passing on the street near 
home’ currently [2.18 (1.25–3.78)]; positive SPT [1.91 (1.49–2.46)] and 
elevated FENO [1.92 (1.40–2.64)], but not asIgE or total IgE (Table 5). 
These results were similar for ARDs in the last 12 months, except 
this time the association with asIgE was statistically significant [1.85 
(1.14–3.01)] (Table S2). Similar results were observed for risk factors 
associated with ARDs among non-asthma controls only (Table S3).
3.6 | Risk factors associated with positive skin 
prick test
Children with positive SPT were more likely than SPT-negative chil-
dren to report having a father [1.36 (1.02–1.81)] and/or a mother 
with tertiary education [1.72 (1.29–2.30)]; a father's [1.41 (1.06–
1.87)] and mother's history of allergic disease [1.28 (1.00–1.63)]; 
residing in the city at birth [1.83 (1.17–2.86)]; the highest reported 
frequency of ‘trucks passing on the street near their home’ currently 
[2.26 (1.45–3.55)]; and were more likely to have elevated FENO 
[4.38 (3.29–5.82)], allergen-specific [25.91 (10.53–63.80)] and total 
IgE (Table 6). Similar results were observed in the subgroup analysis 
of only children without asthma.
For urticarial rash, the statistically significant associated risk fac-
tors were a father's and mother's history of allergic disease, reported 
increased frequency of de-worming and of ‘trucks passing on the 
street near home’ in the last 12 months, but not SPT, asIgE and total 
IgE (Table S4).
Other potential factors, including maternal smoking during 
pregnancy (3%), current smoking by anyone in the household 
TA B L E  4   Risk factors for eczema among schoolchildren in Uganda (N = 1691)
Characteristics
Eczema ever
Adj. OR1  (95% CI) p-valueYes (N = 265) No (N = 1426)
Age, years Mean (SD) 11.55 (3.20) 11.02 (3.11) 1.06 (1.01–1.12) .01
Girls (942) 161 (60.7) 781 (54.8) 1.24 (0.92–1.69) .16
Father's history of allergic disease [m = 148]
Yes (363) 87 (34.8) 276 (21.3) 2.19 (1.56–3.09) <.0001
Mother's history of allergic disease [m = 125]
Yes (592) 124 (49.6) 468 (35.6) 1.94 (1.42–2.67) <.0001
Area of residence at the time of the child's birth
Rural (354) 60 (22.6) 294 (20.6) 1 .03
Town (1188) 168 (63.4) 1020 (71.5) 0.81 (0.56–1.17)
City (149) 37 (14.0) 112 (7.9) 1.55 (0.91–2.63)a
Frequency of ‘trucks passing on street near child's home’ at enrolment
Rarely (944) 137 (51.7) 807 (56.6) 1 .05
Frequently (624) 96 (36.2) 528 (37.0) 1.14 (0.82–1.59)
Almost all the time (123) 32 (12.1) 91 (6.4) 1.94 (1.14–3.32)b
Use of de-worming medication in last 12 months [m = 1]
None (578) 84 (31.7) 494 (34.7) 1 .006
Once (732) 97 (36.6) 635 (44.5) 0.89 (0.62–1.27)
≥Twice (380) 84 (31.7) 296 (20.8) 1.63 (1.10–2.43)c
Any helminth infection2  at enrolment [m = 129]
Yes (212) 28 (11.2) 184 (14.0) 0.76 (0.47–1.25) .28
Skin Prick Test response to any of 7 allergens at enrolment [m = 35]
Positive (≥3 mm) (657) 121 (46.0) 536 (38.5) 1.26 (0.92–1.72) .15
Allergen-specific IgE at enrolment (N = 397)3 
Atopic (≥0.35 kUA/L) (251) 48 (73.8) 203 (61.1) 1.41 (0.69–2.88) .34
Total IgE at enrolment (N = 398)
Median (95% CI) kU/L 431.4 (183.7–639.4) 335.4 (274.0–413.5) 1.00 (0.9998–1.0002) .94
Abbreviations: Adj. OR, adjusted odds ratio; CI, confidence interval; m, missing; N, number; SD, standard deviation; Columns 2 and 3 represent 
number (%), unless stated otherwise.
1 Adjusted for child's age, sex, area of residence at birth and father's education. Test for trend p-value: a = .50; b = .04; c = .04. 
2 Any of Schistosoma mansoni, Trichuris trichuria, hookworm, and Ascaris lumbricoides infections. 
3 ImmunoCAP®, cut-off > 0.35 kUA/L. 
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(including the child, 11%) and breastfeeding history (74% of children 
breastfed to more than 1 year), were not associated with ARDs. Of 
the 1700 children enrolled in the study and tested for HIV, only 
12 were positive and all were already receiving the recommended 
antiretroviral therapy.
4  | DISCUSSION
We found extensive multi-morbidity and substantial overlap of the 
risk factors for rhinitis, allergic conjunctivitis, eczema, urticarial rash 
and atopic sensitization among schoolchildren in urban Uganda. 
The most consistent risk factors included parental history of aller-
gic disease, city residence at birth, current proximity to a busy road, 
frequent de-worming, positive SPT and elevated FENO, but not al-
lergen-specific IgE or total IgE to crude allergen extracts.
We found that children born in the city (a proxy for mother's 
residence during pregnancy) were at a higher risk of ARDs than 
their counterparts born in the village. Of note, the schools were 
situated in an urban setting, and most of the schoolchildren en-
rolled were in the ‘day section’ of school and commuted daily 
within the study area (a predominantly urban setting). Thus, cur-
rent residence was considered as reasonably uniform and urban. 
This highlights the importance of exposures in early life and is 
consistent with the observation that the prevalence of ARDs is 
higher among children in urban than rural areas in Africa33 and 
other LMICs.11 This observation is also consistent with studies 
from Europe and North America that report a lower risk of ARDs 
among children raised on farms (which are predominantly in rural 
areas), and this has been attributed to early life exposure to farm 
animals.14,34 However, we observed a positive association be-
tween reported early life exposure to farm animals and ARDs. This 
implies that the observed ‘protective rural effect’ in this setting 
could not be explained by exposure to farm animals, consistent 
with studies from other developing countries.35,36
We found a positive association between ARDs and positive 
SPT responses and with elevated FENO, which is consistent with 
underlying allergic inflammation that is common to these condi-
tions.3,4 However, there was a lack of association between asIgE 
(to three crude allergen extracts) and rhinitis, conjunctivitis and 
eczema, despite the standard asIgE assessments and cut-off 
points used, and a strong association between asIgE and SPT reac-
tivity. This lack of association may be explained, at least in part, by 
high levels of cross-reactive IgE to other environmental allergens, 
particularly to cross-reactive carbohydrate determinants,37 as re-
ported by studies in Ghana.38 Indeed, our recent work in Uganda 
showed that associations between asIgE or SPT sensitization and 
clinical allergy outcomes were weak among participants from 
rural, compared to urban, settings.39 Rural residents had a higher 
prevalence of helminths—an important source of ‘environmen-
tal’ antigens.39 Our observations are consistent with the ISAAC 
study, which reported a weaker association between ARDs and 
atopic sensitization in LMICs than in HICs.12 This weak/lack of 
association between ARDs and asIgE has important implications 
for diagnosis and treatment of these conditions in this setting: 
what proportion of these conditions is allergic, and, would immu-
notherapy or biologicals treat as effectively as in HICs? To answer 
these question would require the use of component-resolved di-
agnosis (using purified single protein allergens) to determine IgE 
sensitization, with high cost implications that may be prohibitive 
for routine use in this setting.
The participant characteristics that were consistent across all 
ARDs were the reported high frequency of ‘trucks on the street 
near home’ and reported frequent use of de-worming medication. 
We think ‘trucks near home’ is a proxy for proximity to a busy road, 
and this has been previously found to be positively associated with 
ARDs40,41 and asthma morbidity,42 and this is probably related to in-
creased pollution. Air pollution as a possible risk factor is further 
supported by our observation that children with current rhinitis 
were more likely to report indoor cooking with firewood/charcoal 
stove as main fuel sources, similar to a South African study.43 With 
regard to the reported increased frequency of de-worming among 
children with the different ARDs including asthma,13 we have no 
ready explanation. In Uganda, schoolchildren routinely receive mass 
drug administration with albendazole once a year, but in this study, 
children with ARDs were more likely to report being de-wormed 
twice or more in the last 1 year. There was a trend towards low 
prevalence of helminths among children with ARDs but this was sta-
tistically significant for only ‘rhinitis ever’. The inverse association 
between rhinitis and the tuberculin skin test has been reported pre-
viously in South Africa.44
Among the study limitations, first, we performed standard tests 
for asIgE and total IgE on a randomly selected 400 schoolchildren, 
not the entire sample size of 1700, limiting our power to detect 
weaker associations with rhinitis, conjunctivitis and eczema (we 
had good power to detect strong associations). Secondly, the av-
erage age of the participants was 10 years, and as such, we could 
not obtain detailed information on some exposures in early life. 
Nevertheless, we highlight the importance of environmental expo-
sures in early life in increasing the risk of ARDs in the urban setting. 
Thirdly, we acknowledge that estimates obtained by design weights 
tend to be less precise than the unweighted estimates from an un-
weighted study. Nevertheless, this statistical approach has enabled 
us to cost-effectively contribute valuable information on risk fac-
tors for ARDs from sub-Saharan Africa, using existing data from 
an asthma case-control study. Lastly, the variable ‘father's (and 
mother's) history of allergy’ included ‘history of urticaria’. This may 
have reduced the overall effect sizes, because urticaria may not be 
comparable to other allergy outcomes. However, in terms of risk 
factors, we observed that overall, the risk factors associated with 
urticaria among children were similar to the risk factors associated 
with the other ARDs.
The strength of this study is the large sample size and the 
weighed analysis, which make our findings generalizable to 
schoolchildren in urban areas in Uganda and probably in sub-Saha-
ran Africa. The risk factors associated with rhinitis, conjunctivitis, 
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eczema and atopic sensitization (SPT) were similar to the risk fac-
tors for asthma reported in our earlier work,13 even in the sub-
group analysis of children without asthma. Given the similarity 
in risk factors and the extensive overlap of these ARDs among 
children, it is possible that these conditions have the same under-
lying cause and, as such, should be investigated as one entity in 
population studies. Multi-morbidity of the ARDs has been exten-
sively demonstrated in birth cohorts in HICs.6,7,45 The hypothesis 
of shared underlying disease mechanisms for the different ARDs 
is supported by studies that show the role of shared genetic and 
environmental factors.46 The specific shared early life lifestyle and 
environmental risk factors have not been identified, but there are 
important differences with findings from HICs: in LMICs setting, 
there is possibly a reduced role of asIgE and exposure to farm 
animals, an increased risk associated with higher parental educa-
tion and socio-economic status47 and urbanization.9 Investigating 
these differences will increase our understanding of underlying 
causes of all allergy-related diseases.
TA B L E  5   Risk factors for having ever had any of rhinitis, conjunctivitis, eczema and asthma among Ugandan schoolchildren (N = 1693)
Characteristics
Allergy-related diseases—ever
Adj. OR1  (95% CI) p-valueYes (N = 1195) No (N = 498)
Age, years Mean (SD) 11.29 10.64 1.06 (1.02–1.10) .003
Girls (942) 680 (56.9) 262 (52.6) 1.28 (1.02–1.61) .03
Father's history of allergic disease [m = 150]
Yes (363) 313 (28.5) 50 (11.2) 2.64 (1.89–3.70) <.0001
Mother's history of allergic disease [m = 127]
Yes (592) 483 (43.1) 109 (24.4) 2.21 (1.70–2.86) <.0001
Area of residence at the time of the child's birth [m = 1]
Rural (355) 234 (19.6) 121 (24.3) 1 .01
Town (1188) 835 (69.9) 353 (70.9) 1.06 (0.81–1.40)
City (149) 125 (10.5) 24 (4.8) 2.12 (1.26–3.57)a
Exposure to animals in first 5 years of life [m = 60]
Yes (615) 454 (39.2) 161 (33.8) 1.41 (1.11–1.80) .005
Frequency of ‘trucks passing on street near child's home’ at enrolment [m = 1]
Rarely (945) 626 (52.4) 319 (64.1) 1 .001
Frequently (624) 464 (38.9) 160 (32.1) 1.40 (1.10–1.78)
Almost all the time (123) 104 (8.7) 19 (3.8) 2.18 (1.25–3.78)b
Use of de-worming medication in last 12 months [m = 3]
None (578) 384 (32.2) 194 (39.0) 1 <.0001
Once (732) 491 (41.2) 241 (48.4) 0.95 (0.75–1.22)
≥Twice (380) 317 (26.6) 63 (12.6) 2.12 (1.51–2.99)c
Any helminth infection at enrolment [m = 130]
Yes (212) 133 (12.0) 79 (17.3) 0.73 (0.53–1.02) .06
Tuberculin skin test induration at enrolment [N = 961]
Positive (≥10 mm) (143) 88 (13.1) 55 (19.0) 0.60 (0.39–0.90) .01
Skin Prick Test response to any of 7 allergens at enrolment [m = 36]
Positive (≥3 mm) (657) 529 (45.2) 128 (26.3) 1.91 (1.49–2.46) <.0001
Fractional exhaled nitric oxide levels at enrolment [m = 80]
Elevated (≥35 ppb) (381) 321 (27.7) 60 (13.2) 1.92 (1.40–2.64) <.0001
Allergen-specific IgE at enrolment (N = 398)2 
Atopic (≥0.35 kUA/L) (252) 203 (67.2) 49 (51.0) 1.54 (0.92–2.56) .10
Total IgE (N = 398) Median (95% CI) kU/L 348.2 (279.9–465.3) 310.0 (187.6–381.5) 0.9998 (0.9996–1.0001) .22
Abbreviations: Adj. OR, adjusted odds ratio; CI, confidence interval; m, missing; N = number; SD, standard deviation; Columns 2 and 3 represent 
number (%), unless stated otherwise.
1Adjusted for child's age, sex, area of residence at birth and father's education. Test for trend p-valve: a = 0.02; b < 0.0001; c < 0.0001. 
2ImmunoCAP, cut-off > 0.35 kUA/L. 
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5  | CONCLUSION
We found extensive multi-morbidity of, and overlap in the risk factors 
associated with, rhinitis, conjunctivitis and eczema—similar to asthma 
risk factors—among schoolchildren in urban Uganda. This suggests a 
similar underlying cause for all ARDs, associated with early life expo-
sure to urban lifestyles and environment in Uganda. The rapid urbaniza-
tion and population growth in Africa provides an excellent opportunity 
to identify the specific cause. This calls for epidemiological research to 
investigate the causes of ARDs in urban Africa, as one disease entity.
TA B L E  6   Risk factors for skin prick test reactivity among schoolchildren in Uganda (N = 1661)
Characteristics
Skin prick test1 
Adj. OR2  (95% CI) p-valuePos. (N = 658) Neg. (N = 1003)
Age, years Mean (SD) 11.18 (3.10) 11.08 (3.14) 1.03 (1.00–1.07) .08
Girls (930) 308 (46.8) 622 (62.0) 0.57 (0.45–0.71) <.0001
Father's highest education level [m = 25]
None/Primary (425) 147 (22.5) 278 (28.3) 1 .01
Secondary (585) 215 (32.9) 370 (37.6) 0.92 (0.68–1.23)
Tertiary (626) 291 (44.6) 335 (34.1) 1.36 (1.02–1.81)a
Mother's highest education level [m = 26]
None/Primary (569) 186 (28.5) 383 (39.0) 1 .001
Secondary (590) 229 (35.1) 361 (36.8) 1.26 (0.96–1.64)
Tertiary (476) 238 (36.4) 238 (24.2) 1.72 (1.29–2.30)b
Father's history of allergic disease [m = 125]
Yes (356) 178 (29.2) 178 (19.7) 1.41 (1.06–1.87) .02
Mother's history of allergic disease [m = 95]
Yes (577) 264 (39.7) 331 (36.1) 1.28 (1.00–1.63) .05
Area of residence at the time of the child's birth [m = 4]
Rural (348) 113 (17.2) 235 (23.5) 1 .03
Town (1164) 467 (71.1) 697 (69.7) 1.19 (0.89–1.59)
City (145) 77 (11.7) 68 (6.8) 1.83 (1.17–2.86)c
Frequency of ‘trucks passing on street near child's home’ at enrolment [m = 4]
Rarely (923) 340 (51.8) 583 (58.3) 1 .001
Frequently (615) 255 (38.8) 360 (36.0) 1.21 (0.95–1.54)
Almost all the time (119) 62 (9.4) 57 (5.7) 2.26 (1.45–3.55)d
Use of de-worming medication in last 12 months [m = 6]
None (572) 221 (33.6) 351 (35.2) 1 .68
Once (713) 281 (42.8) 432 (43.3) 0.97 (0.75–1.25)
≥Twice (370) 155 (23.6) 215 (21.5) 0.87 (0.64–1.19)e
Any helminth infection3  at enrolment [m = 119]
Yes (211) 73 (11.9) 138 (14.8) 0.76 (0.54–1.08) .13
Fractional exhaled nitric oxide levels at enrolment [m = 74]
Elevated (≥35 ppb) (380) 261 (41.3) 119 (12.5) 4.38 (3.29–5.82) <.0001
Allergen-specific IgE at enrolment (N = 395)4 
Atopic (≥0.35 kUA/L) (251) 156 (94.5) 95 (41.3) 25.91 (10.53–63.80) <.0001
Total IgE at enrolment (N = 396)
Median (95% CI) kU/L 733.2 (587.6–892.7) 179.0 (123.1–238.7) 1.0004 (1.0001–1.0008) .01
Abbreviations: Adj. OR, adjusted odds ratio; CI, confidence interval; m, missing; N, number; Neg, Negative; Pos, positive; SD, standard deviation; 
Columns 2 and 3 represent number (%), unless stated otherwise.
1Whole allergen extracts of Blomia tropicalis, Dermatophagoides mix, cockroach, peanut, cat, weeds pollen mix and mould mix. 
2Adjusted for child's age, sex, area of residence at birth and father's education. Test for trend p-value: a = .03; b = <.0001; c = .02; d = .001; e = .43. 
3 Any of Schistosoma mansoni, Trichuris trichuria, hookworm, and Ascaris lumbricoides infections. 
4 allergen extracts (Dermatophagoides, cockroach and peanut), using ImmunoCAP® on a random sample of 400; standard cut-off > 0.35 kUA/L. 
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